|
1
|
McMurray JJ, Adamopoulos S, Anker SD,
Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C,
Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GY, Maggioni AP,
Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH,
Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA,
Zannad F and Zeiher A; Task Force for the Diagnosis and Treatment
of Acute and Chronic Heart Failure 2012 of the European Society of
Cardiology. Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C,
Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J,
Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U,
Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, McDonagh
T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M,
Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF,
Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn
S, Parissis JT and Ponikowski P; ESC Committee for Practice
Guidelines. ESC guidelines for the diagnosis and treatment of acute
and chronic heart failure 2012: The Task Force for the Diagnosis
and Treatment of Acute and Chronic Heart Failure 2012 of the
European Society of Cardiology. Developed in collaboration with the
Heart Failure Association (HFA) of the ESC. Eur Heart J.
33:1787–1847. 2012.
|
|
2
|
Konstam MA, Kramer DG, Patel AR, Maron MS
and Udelson JE: Left ventricular remodeling in heart failure:
current concepts in clinical significance and assessment. JACC
Cardiovasc Imaging. 4:98–108. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lerman A and Zeiher AM: Endothelial
function: cardiac events. Circulation. 111:363–368. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Adamopoulos S, Parissis JT and Kremastinos
DT: Endothelial dysfunction in chronic heart failure: clinical and
therapeutic implications. Eur J Intern Med. 13:233–239. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Scherrer-Crosbie M, Ullrich R, Bloch KD,
Nakajima H, Nasseri B, Aretz HT, Lindsey ML, Vançon AC, Huang PL,
Lee RT, Zapol WM and Picard MH: Endothelial nitric oxide synthase
limits left ventricular remodeling after myocardial infarction in
mice. Circulation. 104:1286–1291. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Prasad A, Higano ST, Al Suwaidi J, Holmes
DR Jr, Mathew V, Pumper G, Lennon RJ and Lerman A: Abnormal
coronary microvascular endothelial function in humans with
asymptomatic left ventricular dysfunction. Am Heart J. 146:549–554.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shiojima I, Sato K, Izumiya Y, Schiekofer
S, Ito M, Liao R, Colucci WS and Walsh K: Disruption of coordinated
cardiac hypertrophy and angiogenesis contributes to the transition
to heart failure. J Clin Invest. 115:2108–2118. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Seino S and Miki T: Physiological and
pathophysiological roles of ATP-sensitive K+ channels.
Prog Biophys Mol Biol. 81:133–176. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yoshida H, Feig JE, Morrissey A, Ghiu IA,
Artman M and Coetzee WA: KATP channels of primary human
coronary artery endothelial cells consist of a heteromultimeric
complex of kir6.1, kir6.2, and sur2b subunits. J Mol Cell Cardiol.
37:857–869. 2004.
|
|
10
|
Nichols CG, Singh GK and Grange DK:
KATP channels and cardiovascular disease: suddenly a
syndrome. Circ Res. 112:1059–1072. 2013.
|
|
11
|
Gao S, Long CL, Wang RH and Wang H:
KATP activation prevents progression of cardiac
hypertrophy to failure induced by pressure overload via protecting
endothelial function. Cardiovasc Res. 83:444–456. 2009.
|
|
12
|
Tang Y, Long CL, Wang RH, Cui W and Wang
H: Activation of SUR2B/Kir6.1 subtype of adenosine
triphosphate-sensitive potassium channel improves pressure
overload-induced cardiac remodeling via protecting endothelial
function. J Cardiovasc Pharmacol. 56:345–353. 2010. View Article : Google Scholar
|
|
13
|
Chen Y, Pan Z, Cui W and Wang H:
Selectivity of new iptakalim derivatives on the subtypes of
ATP-sensitive potassium channels. Chin Pharmacol Bull.
24:1427–1430. 2008.
|
|
14
|
Wei H, Cao YQ, Zhang JD, Peng Z, Yang DF,
Liu JY, Shi YP, Yang YL and Wang H: Protective effects of
SUR2B/Kir6.1 potassium channel opener natakalim against RAVECs
injuries induced by hypoxia. Chin J Appl Physiol. 28:241–244.
2012.PubMed/NCBI
|
|
15
|
Goldman S and Raya TE: Rat infarct model
of myocardial infarction and heart failure. J Card Fail. 1:169–177.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Velagaleti RS, Pencina MJ, Murabito JM,
Wang TJ, Parikh NI, D’Agostino RB, Levy D, Kannel WB and Vasan RS:
Long-term trends in the incidence of heart failure after myocardial
infarction. Circulation. 118:2057–2062. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ezekowitz JA, Kaul P, Bakal JA, Armstrong
PW, Welsh RC and McAlister FA: Declining in-hospital mortality and
increasing heart failure incidence in elderly patients with first
myocardial infarction. J Am Coll Cardiol. 53:13–20. 2009.
View Article : Google Scholar
|
|
18
|
Krzemiński TF, Nozyński JK, Grzyb J and
Porc M: Wide-spread myocardial remodeling after acute myocardial
infarction in rat. Features for heart failure progression. Vascul
Pharmacol. 48:100–108. 2008.PubMed/NCBI
|
|
19
|
Marti CN, Gheorghiade M, Kalogeropoulos
AP, Georgiopoulou VV, Quyyumi AA and Butler J: Endothelial
dysfunction, arterial stiffness, and heart failure. J Am Coll
Cardiol. 60:1455–1469. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Khazaei M, Moien-Afshari F and Laher I:
Vascular endothelial function in health and diseases.
Pathophysiology. 15:49–67. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yin WH, Chen YH, Wei J, Jen HL, Huang WP,
Young MS, Chen DC and Liu PL: Associations between endothelin-1 and
adiponectin in chronic heart failure. Cardiology. 118:207–216.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Francois H, Athirakul K, Howell D, Dash R,
Mao L, Kim HS, Rockman HA, Fitzgerald GA, Koller BH and Coffman TM:
Prostacyclin protects against elevated blood pressure and cardiac
fibrosis. Cell Metab. 2:201–207. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Feng Q, Song W, Lu X, Hamilton JA, Lei M,
Peng T and Yee SP: Development of heart failure and congenital
septal defects in mice lacking endothelial nitric oxide synthase.
Circulation. 106:873–879. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Janssens S, Pokreisz P, Schoonjans L,
Pellens M, Vermeersch P, Tjwa M, Jans P, Scherrer-Crosbie M, Picard
MH, Szelid Z, Gillijns H, Van de Werf F, Collen D and Bloch KD:
Cardiomyocyte-specific overexpression of nitric oxide synthase 3
improves left ventricular performance and reduces compensatory
hypertrophy after myocardial infarction. Circ Res. 94:1256–1262.
2004. View Article : Google Scholar
|
|
25
|
Takimoto Y, Aoyama T, Keyamura R, Shinoda
E, Hattori R, Yui Y and Sasayama S: Differential expression of
three types of nitric oxide synthase in both infarcted and
non-infarcted left ventricles after myocardial infarction in the
rat. Int J Cardiol. 76:135–145. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu YH, Carretero OA, Cingolani OH, Liao
TD, Sun Y, Xu J, Li LY, Pagano PJ, Yang JJ and Yang XP: Role of
inducible nitric oxide synthase in cardiac function and remodeling
in mice with heart failure due to myocardial infarction. Am J
Physiol Heart Circ Physiol. 289:H2616–H2623. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Starling RC: Inducible nitric oxide
synthase in severe human heart failure: impact of mechanical
unloading. J Am Coll Cardiol. 45:1425–1427. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tousoulis D, Charakida M and Stefanadis C:
Inflammation and endothelial dysfunction as therapeutic targets in
patients with heart failure. Int J Cardiol. 100:347–353. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhao RJ and Wang H: Chemerin/ChemR23
signaling axis is involved in the endothelial protection by
KATP channel opener iptakalim. Acta Pharmacol Sin.
32:573–580. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kolettis TM, Barton M, Langleben D and
Matsumura Y: Endothelin in coronary artery disease and myocardial
infarction. Cardiol Rev. 21:249–256. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Böhm F and Pernow J: The importance of
endothelin-1 for vascular dysfunction in cardiovascular disease.
Cardiovasc Res. 76:8–18. 2007.PubMed/NCBI
|
|
32
|
Spieker LE, Noll G, Ruschitzka FT and
Lüscher TF: Endothelin receptor antagonists in congestive heart
failure: a new therapeutic principle for the future? J Am Coll
Cardiol. 37:1493–1505. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nguyen QT, Cernacek P, Sirois MG,
Calderone A, Lapointe N, Stewart DJ and Rouleau JL: Long-term
effects of nonselective endothelin A and B receptor antagonism in
postinfarction rat: importance of timing. Circulation.
104:2075–2081. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Harding P and Murray DB: The contribution
of prostaglandins versus prostacyclin in ventricular remodeling
during heart failure. Life Sci. 89:671–676. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xiao CY, Hara A, Yuhki K, Fujino T, Ma H,
Okada Y, Takahata O, Yamada T, Murata T, Narumiya S and Ushikubi F:
Roles of prostaglandin I2 and thromboxane A2
in cardiac ischemia-reperfusion injury: a study using mice lacking
their respective receptors. Circulation. 104:2210–2015.
2001.PubMed/NCBI
|
|
36
|
Chan EC, Dusting GJ, Guo N, Peshavariya
HM, Taylor CJ, Dilley R, Narumiya S and Jiang F: Prostacyclin
receptor suppresses cardiac fibrosis: role of CREB phosphorylation.
J Mol Cell Cardiol. 49:176–185. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yuhki K, Kojima F, Kashiwagi H, Kawabe J,
Fujino T, Narumiya S and Ushikubi F: Roles of prostanoids in the
pathogenesis of cardiovascular diseases: novel insights from
knockout mouse studies. Pharmacol Ther. 129:195–205. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Minamino T and Hori M: Protecting
endothelial function: a novel therapeutic target of atp-sensitive
potassium channel openers. Cardiovasc Res. 73:448–449. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang H, Tang Y, Wang L, Long CL and Zhang
YL: ATP-sensitive potassium channel openers and
2,3-dimethyl-2-butylamine derivatives. Curr Med Chem. 14:133–155.
2007. View Article : Google Scholar : PubMed/NCBI
|
